Francesco Maria Lavino, Chief Commercial Officer at Nabriva Therapeutics plc (NBRV), bought 1,569 shares at $6.29 ($10K) on 2017-11-29, disclosed to the SEC on 2017-12-01.
Open-market purchase of $10k NBRV by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |